Filed: May 16, 2011
Latest Update: Feb. 22, 2020
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 10-1685 _ IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/ DEXFENFLURAMINE) PRODUCT LIABILITY LITIGATION Judith Dahlka, Appellant _ On Appeal from the United States District Court for the Eastern District of Pennsylvania (D.C. Civil Action No. 2-99-cv-20593, MDL No. 1203) District Judge: Honorable Harvey Bartle, III _ Submitted Pursuant to Third Circuit LAR 34.1(a) May 12, 2011 Before: SLOVITER, FISHER and WEIS, Circuit Judge
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 10-1685 _ IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/ DEXFENFLURAMINE) PRODUCT LIABILITY LITIGATION Judith Dahlka, Appellant _ On Appeal from the United States District Court for the Eastern District of Pennsylvania (D.C. Civil Action No. 2-99-cv-20593, MDL No. 1203) District Judge: Honorable Harvey Bartle, III _ Submitted Pursuant to Third Circuit LAR 34.1(a) May 12, 2011 Before: SLOVITER, FISHER and WEIS, Circuit Judges..
More
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
___________
No. 10-1685
___________
IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/
DEXFENFLURAMINE)
PRODUCT LIABILITY LITIGATION
Judith Dahlka, Appellant
____________________________________
On Appeal from the United States District Court
for the Eastern District of Pennsylvania
(D.C. Civil Action No. 2-99-cv-20593, MDL No. 1203)
District Judge: Honorable Harvey Bartle, III
____________________________________
Submitted Pursuant to Third Circuit LAR 34.1(a)
May 12, 2011
Before: SLOVITER, FISHER and WEIS, Circuit Judges
(Opinion filed May 16, 2011)
___________
OPINION
___________
PER CURIAM.
Judith Dahlka appeals from the order of the District Court denying her
claim for benefits from the AHP Settlement Trust (“Trust”). We will affirm.
I.
Dahlka is a member of the certified settlement class who seeks benefits
under the Diet Drugs Nationwide Class Action Settlement Agreement (“Settlement
Agreement”). We have previously discussed the background of this litigation, the
relevant terms of the Settlement Agreement and the relevant medical issues at some
length, and we need not do so here. See, e.g., In re Diet Drugs, 543 F.3d 179, 181-90 (3d
Cir. 2008).
Dahlka filed her claim with the Trust seeking $538,973 in benefits under
Matrix A-1, Level II of the Settlement Agreement. That claim required her to show a
reasonable medical basis for concluding that she has a qualifying condition, which in this
case would be mitral regurgitation of at least a moderate level together with an enlarged
left atrium. To that end, she submitted a February 19, 2002 echocardiogram together
with a “Green Form” in which Dr. Linda Crouse attested that the echocardiogram showed
moderate mitral regurgitation with an enlarged left atrium. She later withdrew that Green
Form and submitted a second one in which Dr. Elias Kassab made the same attestation
based on the same echocardiogram.
The Trust referred Dahlka‟s claim to an independent auditing cardiologist,
Dr. Michele Penkala. Dr. Penkala concluded that there was no reasonable medical basis
for Dr. Kassab‟s finding of moderate mitral regurgitation. On that basis, the Trust issued
a post-audit determination denying Dahlka‟s claim. Dahlka contested the determination
and submitted a second opinion that her echocardiogram shows moderate mitral
regurgitation, this one from Dr. Peter Mancini. The Trust affirmed.
Dahlka contested that determination as well, so the Trust applied to the
District Court for an order requiring Dahlka to show cause why her claim should be paid.
2
The District Court issued the order and referred the matter to a Special Master, who
appointed Dr. Gary J. Vigilante as an independent technical advisor. Dr. Vigilante issued
a report disagreeing with Dr. Penkala in certain respects but agreeing that there is no
reasonable basis to conclude that Dahlka suffers from moderate mitral regurgitation. The
Special Master then forwarded the record to the District Court for review. By order
entered February 22, 2010, the District Court affirmed the Trust‟s denial of Dahlka‟s
claim. Dahlka appeals.1
II.
We have jurisdiction under 28 U.S.C. § 1291 to review the District Court‟s
denial of Dahlka‟s claim. See In re Diet Drugs, 543 F.3d at 184 n.10. “We review a
District Court‟s exercise of its equitable authority to administer and implement a class
action settlement for abuse of discretion.”
Id. “„[T]o find an abuse of discretion the
District Court‟s decision must rest on „a clearly erroneous finding of fact, an errant
conclusion of law or an improper application of law to fact.‟”
Id. (citation omitted). In
this case, the District Court thoroughly reviewed the record and concluded that Dahlka
has not met her burden to show a reasonable basis for concluding that she suffers from
moderate mitral regurgitation. See
id. at 181. Dahlka raises essentially four challenges
to that conclusion, but each lacks merit.
1
On March 8, 2010, the District Court denied reimbursement of the fee Dahlka paid for
the technical advisor. Dahlka mailed her notice of appeal before that ruling (and thus did
not mention it), and she never amended her notice or filed another. Thus, although
Dahlka refers to the ruling in her brief, we lack jurisdiction to review it.
3
First, Dahlka argues that her three cardiologists all agree that her
echocardiogram shows moderate mitral regurgitation, while the opinions of the auditing
physician Dr. Penkala and the technical advisor Dr. Vigilante conflict with each other.
According to Dahlka, Dr. Vigilante “basically said that the auditor‟s report was medically
unreasonable because he found that I had mild mitral valve regurgitation and an enlarged
left atrium while the auditor stated I had neither,” such that “the technical advisor did not
agree with any aspect of the auditor‟s report.”
That is not the case. It is true that Dr. Vigilante found a reasonable basis
for concluding that Dahlka has an enlarged left atrium, but both Dr. Vigilante and Dr.
Penkala agreed that there was no reasonable basis to conclude that Dahlka‟s mitral
regurgitation was at the moderate level. Dr. Penkala opined that Dahlka‟s mitral
regurgitation was “only trivial or physiologic” (Supp. Appx. at 65), while Dr. Vigilante
opined that it was only “mild” (id. at 71-72). Their opinions are thus consistent in
relevant part, and Dahlka has not meaningfully challenged them. After reviewing the
record, we cannot say that the District Court clearly erred or otherwise abused its
discretion in relying on those opinions.
Second, Dahlka argues that Drs. Kassab and Mancini based their opinions
on measurements independent from those in the February 19, 2002 echocardiogram that
Drs. Penkala and Vigilante found were flawed. Dahlka cites no evidence of record for
that proposition. To the contrary, Dahlka acknowledges in her brief that Dr. Kassab
4
“performed another reading of my echocardiogram” (Appellant‟s Br. at 3), and Dr.
Kassab‟s attestation states that he relied on the February 19 echocardiogram as well
(Supp. Appx. at 37). As for Dr. Mancini, the District Court specifically discussed that
issue and Dahlka has alleged no error in that regard. (Dist. Ct. Op. at 12-13 & n.13.)2
Third, Dahlka argues that the District Court failed to consider a
phenomenon called “inter-reader variability,” which she takes to mean that mere
disagreements among physicians do not render any of their conclusions medically
unreasonable. Once again, however, both Dr. Vigilante (Supp. Appx. at 72) and the
District Court (Dist. Ct. Op. at 16) specifically took inter-reader variability into account,
and Dahlka has not challenged the manner in which they did so.
Finally, Dahlka argues that the District Court was biased by the inclusion in
her record of the original attestation of Dr. Crouse. According to Dahlka, she withdrew
that attestation after learning that Dr. Crouse had been “accused of mis-
reading/interpreting echocardiograms,” and Dr. Crouse‟s attestation thus should not have
been included in her record. There is no basis for concluding that the District Court was
biased by that inclusion. Indeed, Dahlka herself continues to include Dr. Crouse in her
repeated references to the “three board-certified cardiologists” who opined that she
2
Dahlka has filed a motion to expand the record on appeal to include, inter alia, a July
30, 2007 letter from Dr. Mancini that she submitted to the District Court and that the
District Court discussed. We grant her motion to the limited extent that we will consider
the letter, though in doing so we do not suggest that the District Court erred in excluding
it from the record. Dr. Mancini‟s letter does not state that he took independent
measurements. Dahlka‟s motion to expand the record is otherwise denied.
5
suffers from moderate mitral regurgitation. As the Trust argues, she cannot have it both
ways.3
Accordingly, we will affirm the judgment of the District Court.
3
In addition to the denial of her claim, Dahlka challenges the validity of an amendment
to the Settlement Agreement and alleges general improprieties in its administration.
Those claims were not before the District Court and are not properly before us in the first
instance. See In re Diet Drugs, 385 F.3d 386, 396 (3d Cir. 2004).
6
